A carregar...

Adjuvant and neoadjuvant small-molecule targeted therapy in high-risk renal cell carcinoma

BACKGROUND: Non-localized renal cell carcinoma (rcc) carries a poor prognosis with a significant risk of mortality for patients. Traditionally, interleukin-2 and interferon alfa have been administered in this setting, with high toxicity and limited improvement in cancer-specific survival. However, n...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kapoor, A., Gharajeh, A., Sheikh, A., Pinthus, J.
Formato: Artigo
Idioma:Inglês
Publicado em: Multimed Inc. 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2687799/
https://ncbi.nlm.nih.gov/pubmed/19478895
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!